3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
10
Ovarian Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
3
Lung Neoplasms
3
Carcinoma, Ovarian Epithelial
3
Carcinoma, Non-Small-Cell Lung
3
Urinary Bladder Neoplasms
2
Rectal Neoplasms
2
Melanoma
2
Liver Neoplasms
2
Head and Neck Neoplasms
2
Fallopian Tube Neoplasms
2
Carcinoma, Renal Cell
2
Carcinoma, Hepatocellular
2
Uterine Cervical Neoplasms
1
Urethral Neoplasms
1
Tobacco Use Disorder
1
Recurrence
1
Precancerous Conditions
1
Pathologic Complete Response
1
Pancreatic Neoplasms
1
Oligodendroglioma
1
Neoplasms
1
Neoplasm Metastasis
1
Kidney Neoplasms
1
Hirschsprung Disease
1
Glioma
1
Ganglion Cysts
1
Gallbladder Neoplasms
1
Endometrial Neoplasms
1
Interventions
Cyclophosphamide
17
fludarabine
13
Dexamethasone
12
Cisplatin
12
Rituximab
10
Gemcitabine
9
Paclitaxel
8
Bendamustine Hydrochloride
8
Lenalidomide
7
Decitabine
7
Cytarabine
7
Carboplatin
7
fludarabine phosphate
6
N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide
6
Etoposide
6
Bortezomib
6
Radiotherapy
5
Injections
5
Azacitidine
5
camrelizumab
4
apatinib
4
Valproic Acid
4
Thalidomide
4
Procarbazine
4
Oxaliplatin
4
Drug Therapy
4
Bevacizumab
4
Antilymphocyte Serum
4
venetoclax
3
pomalidomide
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Recurrence
×
Immunohistochemistry
×
Clear all
NCT02015728
2016-12-15
SEED
Seattle Children's Hospital
Phase NA
Unknown
20 enrolled